BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 35126364)

  • 1. Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease.
    Lötscher F; Seitz L; Simeunovic H; Sarbu AC; Porret NA; Feldmeyer L; Borradori L; Bonadies N; Maurer B
    Front Immunol; 2021; 12():800149. PubMed ID: 35126364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
    van der Made CI; Potjewijd J; Hoogstins A; Willems HPJ; Kwakernaak AJ; de Sevaux RGL; van Daele PLA; Simons A; Heijstek M; Beck DB; Netea MG; van Paassen P; Elizabeth Hak A; van der Veken LT; van Gijn ME; Hoischen A; van de Veerdonk FL; Leavis HL; Rutgers A
    J Allergy Clin Immunol; 2022 Jan; 149(1):432-439.e4. PubMed ID: 34048852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Looking beyond VEXAS: Coexistence of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome.
    Oganesyan A; Hakobyan Y; Terrier B; Georgin-Lavialle S; Mekinian A
    Semin Hematol; 2021 Oct; 58(4):247-253. PubMed ID: 34802547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
    Patel N; Dulau-Florea A; Calvo KR
    Semin Hematol; 2021 Oct; 58(4):204-211. PubMed ID: 34802541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
    Koster MJ; Kourelis T; Reichard KK; Kermani TA; Beck DB; Cardona DO; Samec MJ; Mangaonkar AA; Begna KH; Hook CC; Oliveira JL; Nasr SH; Tiong BK; Patnaik MM; Burke MM; Michet CJ; Warrington KJ
    Mayo Clin Proc; 2021 Oct; 96(10):2653-2659. PubMed ID: 34489099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold.
    Lacombe V; Prevost M; Bouvier A; Thépot S; Chabrun F; Kosmider O; Lacout C; Beucher A; Lavigne C; Geneviève F; Urbanski G
    Br J Haematol; 2021 Oct; 195(2):286-289. PubMed ID: 34340250
    [No Abstract]   [Full Text] [Related]  

  • 7. UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.
    Shaukat F; Hart M; Burns T; Bansal P
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):134-139. PubMed ID: 34480172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEXAS syndrome in a woman.
    Barba T; Jamilloux Y; Durel CA; Bourbon E; Mestrallet F; Sujobert P; Hot A
    Rheumatology (Oxford); 2021 Nov; 60(11):e402-e403. PubMed ID: 33930131
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and genetic features of MDS associated with VEXAS syndrome].
    Kunimoto H
    Rinsho Ketsueki; 2024; 65(4):255-264. PubMed ID: 38684436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patients.
    Olteanu H; Patnaik M; Koster MJ; Herrick JL; Chen D; He R; Viswanatha D; Warrington KJ; Go RS; Mangaonkar AA; Kourelis T; Hines A; Gibson SE; Peterson JF; Reichard KK
    Am J Clin Pathol; 2024 Jun; 161(6):609-624. PubMed ID: 38413044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic Mutations in
    Beck DB; Ferrada MA; Sikora KA; Ombrello AK; Collins JC; Pei W; Balanda N; Ross DL; Ospina Cardona D; Wu Z; Patel B; Manthiram K; Groarke EM; Gutierrez-Rodrigues F; Hoffmann P; Rosenzweig S; Nakabo S; Dillon LW; Hourigan CS; Tsai WL; Gupta S; Carmona-Rivera C; Asmar AJ; Xu L; Oda H; Goodspeed W; Barron KS; Nehrebecky M; Jones A; Laird RS; Deuitch N; Rowczenio D; Rominger E; Wells KV; Lee CR; Wang W; Trick M; Mullikin J; Wigerblad G; Brooks S; Dell'Orso S; Deng Z; Chae JJ; Dulau-Florea A; Malicdan MCV; Novacic D; Colbert RA; Kaplan MJ; Gadina M; Savic S; Lachmann HJ; Abu-Asab M; Solomon BD; Retterer K; Gahl WA; Burgess SM; Aksentijevich I; Young NS; Calvo KR; Werner A; Kastner DL; Grayson PC
    N Engl J Med; 2020 Dec; 383(27):2628-2638. PubMed ID: 33108101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome.
    Kunimoto H; Miura A; Maeda A; Tsuchida N; Uchiyama Y; Kunishita Y; Nakajima Y; Takase-Minegishi K; Yoshimi R; Miyazaki T; Hagihara M; Yamazaki E; Kirino Y; Matsumoto N; Nakajima H
    Int J Hematol; 2023 Oct; 118(4):494-502. PubMed ID: 37062784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
    Guerrero-Bermúdez CA; Cardona-Cardona AF; Ariza-Parra EJ; Arostegui JI; Mensa-Vilaro A; Yague J; Vásquez G; Muñoz-Vahos CH
    Clin Rheumatol; 2022 Nov; 41(11):3565-3572. PubMed ID: 35986821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
    Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
    JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEXAS syndrome.
    Nakajima H; Kunimoto H
    Int J Hematol; 2024 May; ():. PubMed ID: 38819628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of polychondritis-onset refractory organizing pneumonia with cytopaenia diagnosed as VEXAS syndrome: the disease course of 7 years.
    Sakuma M; Tanimura A; Yasui S; Ishiguro K; Kobayashi T; Ohshiro Y; Miyazaki H; Minamimoto R; Okafuji T; Shimozawa K; Ogura G; Miwa A; Yamashita H; Kaneko H
    Rheumatology (Oxford); 2021 Oct; 60(10):e356-e359. PubMed ID: 33839773
    [No Abstract]   [Full Text] [Related]  

  • 17. A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm.
    Li P; Venkatachalam S; Ospina Cordona D; Wilson L; Kovacsovics T; Moser KA; Miles RR; Beck DB; George T; Tantravahi SK
    Blood Adv; 2022 Jan; 6(2):405-409. PubMed ID: 34649277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.
    Huang H; Zhang W; Cai W; Liu J; Wang H; Qin T; Xu Z; Li B; Qu S; Pan L; Huang G; Gale RP; Xiao Z
    Exp Hematol Oncol; 2021 Mar; 10(1):23. PubMed ID: 33741056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: diagnosis of VEXAS syndrome in a patient with therapy-resistant large vessel vasculitis.
    Boret M; Malfait T
    Acta Clin Belg; 2024 Apr; 79(2):143-147. PubMed ID: 38314661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report.
    Loschi M; Roux C; Sudaka I; Ferrero-Vacher C; Marceau-Renaut A; Duployez N; Passeron T; Cluzeau T
    Bone Marrow Transplant; 2022 Feb; 57(2):315-318. PubMed ID: 34999727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.